Burning Rock Ownership

BNR Stock  USD 5.70  0.06  1.04%   
The market capitalization of Burning Rock Biotech is $59.09 Million. Over half of Burning Rock's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
 
Shares in Circulation  
First Issued
2019-03-31
Previous Quarter
10.3 M
Current Value
10.3 M
Avarage Shares Outstanding
81.6 M
Quarterly Volatility
36.2 M
 
Covid
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burning Rock Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Burning Stock Ownership Analysis

About 64.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.65. Some equities with similar Price to Book (P/B) outperform the market in the long run. Burning Rock Biotech recorded a loss per share of 5.7. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 15th of May 2024. Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the Peoples Republic of China. The company was incorporated in 2014 and is headquartered in Guangzhou, China. Burning Rock operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1394 people. For more info on Burning Rock Biotech please contact the company at 86 20 3403 7871 or go to https://www.brbiotech.com.
Besides selling stocks to institutional investors, Burning Rock also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Burning Rock's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Burning Rock's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Burning Rock Quarterly Liabilities And Stockholders Equity

984.8 Million

Less than 1% of Burning Rock Biotech are currently held by insiders. Unlike Burning Rock's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Burning Rock's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Burning Rock's insider trades

Burning Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Burning Rock is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Burning Rock Biotech backward and forwards among themselves. Burning Rock's institutional investor refers to the entity that pools money to purchase Burning Rock's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Morgan Stanley - Brokerage Accounts2024-12-31
10.7 K
Skyview Investment Advisors, Llc2024-09-30
10 K
Ubs Group Ag2024-12-31
1.4 K
Shen Neil Nanpeng2024-12-31
885
Bnp Paribas Arbitrage, Sa2024-12-31
800
Rhumbline Advisers2024-12-31
580
Tower Research Capital Llc2024-12-31
192
Jpmorgan Chase & Co2024-12-31
120
Citigroup Inc2024-12-31
31.0
Kynam Capital Management, Lp2024-12-31
994.9 K
Massachusetts Financial Services Company2024-12-31
374.4 K
Note, although Burning Rock's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Burning Rock Outstanding Bonds

Burning Rock issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Burning Rock Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Burning bonds can be classified according to their maturity, which is the date when Burning Rock Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Burning Rock Corporate Filings

6K
31st of December 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
26th of November 2024
Other Reports
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
18th of September 2024
Other Reports
ViewVerify

Pair Trading with Burning Rock

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Burning Rock position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burning Rock will appreciate offsetting losses from the drop in the long position's value.

Moving together with Burning Stock

  0.63VOR Vor BiopharmaPairCorr

Moving against Burning Stock

  0.75CMRX ChimerixPairCorr
  0.53CPIX Cumberland PharmaceuticalsPairCorr
  0.44FNA Paragon 28PairCorr
The ability to find closely correlated positions to Burning Rock could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Burning Rock when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Burning Rock - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Burning Rock Biotech to buy it.
The correlation of Burning Rock is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Burning Rock moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Burning Rock Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Burning Rock can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Burning Stock Analysis

When running Burning Rock's price analysis, check to measure Burning Rock's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burning Rock is operating at the current time. Most of Burning Rock's value examination focuses on studying past and present price action to predict the probability of Burning Rock's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burning Rock's price. Additionally, you may evaluate how the addition of Burning Rock to your portfolios can decrease your overall portfolio volatility.